AMJ Podcast | Episode 2: Inside the MDT: Expert Voices in Muscle-Invasive Bladder Cancer Care - European Medical Journal

This site is intended for healthcare professionals

AMJ Podcast | Episode 2: Inside the MDT: Expert Voices in Muscle-Invasive Bladder Cancer Care

This content was funded by AstraZeneca, and is intended for US Healthcare Professionals.


How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer (MIBC)?

This AMJ podcast brings together three leading experts in each speciality to explore best practices in MDT collaboration, patient transitions, and treatment strategy.

Listen now to strengthen your approach to MIBC care.

Chapters:

  • 00:00 – 02:18 | Introductions
  • 02:18 – 10:15 | MDT Collaboration & Best Practices
  • 10:15 – 16:16 | Patient Pathway & Coordination
  • 16:16 – 25:23 | Treatment Decisions & Strategy
  • 25:23 – 33:38 | Immune-Mediated AR Management
  • 33:38 – 38:52 | Key Takeaways

Speakers

Chandler Park, MD1

Gautam Jayram, MD2

Michael White, PA-C3

1. Medical Oncologist, Norton Cancer Institute; & Clinical Faculty, University of Louisville School of Medicine

2. Urologist, Urology Associates, Nashville, TN

3. Physician Assistant, Urology Partners of North Texas

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.